172 related articles for article (PubMed ID: 3681342)
1. Formalin fixed brains are useful for magnetic resonance imaging (MRI) study.
Nagara H; Inoue T; Koga T; Kitaguchi T; Tateishi J; Goto I
J Neurol Sci; 1987 Oct; 81(1):67-77. PubMed ID: 3681342
[TBL] [Abstract][Full Text] [Related]
2. Magnetic resonance imaging pattern in natalizumab-associated progressive multifocal leukoencephalopathy.
Yousry TA; Pelletier D; Cadavid D; Gass A; Richert ND; Radue EW; Filippi M
Ann Neurol; 2012 Nov; 72(5):779-87. PubMed ID: 23280794
[TBL] [Abstract][Full Text] [Related]
3. A pathology-MRI study of the short-T2 component in formalin-fixed multiple sclerosis brain.
Moore GR; Leung E; MacKay AL; Vavasour IM; Whittall KP; Cover KS; Li DK; Hashimoto SA; Oger J; Sprinkle TJ; Paty DW
Neurology; 2000 Nov; 55(10):1506-10. PubMed ID: 11094105
[TBL] [Abstract][Full Text] [Related]
4. Postmortem MR imaging of the brains of patients with AIDS.
Scatliff JH; Kwock L; Chancellor K; Bouldin TW; Kapoor CC; Castillo M
Neuroimaging Clin N Am; 1997 May; 7(2):297-320. PubMed ID: 9113692
[TBL] [Abstract][Full Text] [Related]
5. Inversion recovery ultrashort echo time magnetic resonance imaging: A method for simultaneous direct detection of myelin and high signal demonstration of iron deposition in the brain - A feasibility study.
Sheth VR; Fan S; He Q; Ma Y; Annese J; Switzer R; Corey-Bloom J; Bydder GM; Du J
Magn Reson Imaging; 2017 May; 38():87-94. PubMed ID: 28038965
[TBL] [Abstract][Full Text] [Related]
6. MRI pattern in asymptomatic natalizumab-associated PML.
Wattjes MP; Vennegoor A; Steenwijk MD; de Vos M; Killestein J; van Oosten BW; Mostert J; Siepman DA; Moll W; van Golde AE; Frequin ST; Richert ND; Barkhof F
J Neurol Neurosurg Psychiatry; 2015 Jul; 86(7):793-8. PubMed ID: 25205744
[TBL] [Abstract][Full Text] [Related]
7. Concentric MR patterns in multiple sclerosis. Report of two cases.
Revel MP; Valiente E; Gray F; Beges C; Degos JD; Brugières P; Gaston A
J Neuroradiol; 1993 Dec; 20(4):252-7. PubMed ID: 8308543
[TBL] [Abstract][Full Text] [Related]
8. Multiple sclerosis lesions and irreversible brain tissue damage: a comparative ultrahigh-field strength magnetic resonance imaging study.
Sinnecker T; Mittelstaedt P; Dörr J; Pfueller CF; Harms L; Niendorf T; Paul F; Wuerfel J
Arch Neurol; 2012 Jun; 69(6):739-45. PubMed ID: 22351849
[TBL] [Abstract][Full Text] [Related]
9. Cortical demyelination in PML and MS: Similarities and differences.
Moll NM; Rietsch AM; Ransohoff AJ; Cossoy MB; Huang D; Eichler FS; Trapp BD; Ransohoff RM
Neurology; 2008 Jan; 70(5):336-43. PubMed ID: 17914063
[TBL] [Abstract][Full Text] [Related]
10. Unusual MRI and pathologic findings of progressive multifocal leukoencephalopathy complicating adult Wiskott-Aldrich syndrome.
Matsushima T; Nakamura K; Oka T; Tachikawa N; Sata T; Murayama S; Nukina N; Kanazawa I
Neurology; 1997 Jan; 48(1):279-82. PubMed ID: 9008537
[TBL] [Abstract][Full Text] [Related]
11. Diagnosis of natalizumab-associated progressive multifocal leukoencephalopathy using MRI.
Wattjes MP; Barkhof F
Curr Opin Neurol; 2014 Jun; 27(3):260-70. PubMed ID: 24739400
[TBL] [Abstract][Full Text] [Related]
12. In vivo determination of T1 and T2 in the brain of patients with severe but stable multiple sclerosis.
Larsson HB; Frederiksen J; Kjaer L; Henriksen O; Olesen J
Magn Reson Med; 1988 May; 7(1):43-55. PubMed ID: 3386521
[TBL] [Abstract][Full Text] [Related]
13. Progressive multifocal leukoencephalopathy and relapsing-remitting multiple sclerosis: a comparative study.
Boster A; Hreha S; Berger JR; Bao F; Penmesta R; Tselis A; Endress C; Zak I; Perumal J; Caon C; Vazquez J; Tyler KL; Racke MK; Millis S; Khan O
Arch Neurol; 2009 May; 66(5):593-9. PubMed ID: 19433659
[TBL] [Abstract][Full Text] [Related]
14. MRI in methotrexate-related leukoencephalopathy: Disseminated necrotising leukoencephalopathy in comparison with mild leukoencephalopathy.
Oka M; Terae S; Kobayashi R; Sawamura Y; Kudoh K; Tha KK; Yoshida M; Kaneda M; Suzuki Y; Miyasaka K
Neuroradiology; 2003 Jul; 45(7):493-7. PubMed ID: 12761601
[TBL] [Abstract][Full Text] [Related]
15. Pathological findings correlated with MRI in HIV infection.
Hawkins CP; McLaughlin JE; Kendall BE; McDonald WI
Neuroradiology; 1993; 35(4):264-8. PubMed ID: 8388082
[TBL] [Abstract][Full Text] [Related]
16. Gray matter T2 hypointensity is related to plaques and atrophy in the brains of multiple sclerosis patients.
Bakshi R; Dmochowski J; Shaikh ZA; Jacobs L
J Neurol Sci; 2001 Mar; 185(1):19-26. PubMed ID: 11266686
[TBL] [Abstract][Full Text] [Related]
17. Serial MRI studies in pathologically verified Balò's concentric sclerosis.
Chen CJ; Ro LS; Chang CN; Ho YS; Lu CS
J Comput Assist Tomogr; 1996; 20(5):732-5. PubMed ID: 8797902
[TBL] [Abstract][Full Text] [Related]
18. The role of NMR imaging in the assessment of multiple sclerosis and isolated neurological lesions. A quantitative study.
Ormerod IE; Miller DH; McDonald WI; du Boulay EP; Rudge P; Kendall BE; Moseley IF; Johnson G; Tofts PS; Halliday AM
Brain; 1987 Dec; 110 ( Pt 6)():1579-616. PubMed ID: 3427402
[TBL] [Abstract][Full Text] [Related]
19. Increased cortical grey matter lesion detection in multiple sclerosis with 7 T MRI: a post-mortem verification study.
Kilsdonk ID; Jonkman LE; Klaver R; van Veluw SJ; Zwanenburg JJ; Kuijer JP; Pouwels PJ; Twisk JW; Wattjes MP; Luijten PR; Barkhof F; Geurts JJ
Brain; 2016 May; 139(Pt 5):1472-81. PubMed ID: 26956422
[TBL] [Abstract][Full Text] [Related]
20. Juxtacortical susceptibility changes in progressive multifocal leukoencephalopathy at the gray-white matter junction correlates with iron-enriched macrophages.
Mahajan KR; Amin M; Poturalski M; Lee J; Herman D; Zheng Y; Androjna C; Howell M; Fox RJ; Trapp BD; Jones SE; Nakamura K; Ontaneda D
Mult Scler; 2021 Dec; 27(14):2159-2169. PubMed ID: 33749379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
